关节囊松解 资料

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Topic scope: Both (A) non-operative staged management of primary/secondary adhesive capsulitis (freezing -> frozen -> thawing), including physiotherapy, intra-articular steroid and hydrodilatation; and (B) post-operative rehabilitation after arthroscopic capsular release (ACR).

Defining principle of surgical rehab here (the inversion): Unlike virtually every other shoulder operation -- where a repair (cuff, labrum, pec major, instability) must be protected with a sling and ROM is restricted to avoid disrupting healing tissue -- frozen-shoulder release rehab is the OPPOSITE: the goal is to prevent re-formation of the capsular contracture. So the protocol is immediate, aggressive ROM, usually NO sling, passive + active ROM starting the same day or day 1, with stretching to the end of the freshly gained range. Delay or immobilisation is the enemy (re-stiffening), not the protector. This is the single most important point distinguishing this protocol from the others in this audit.

A. NON-OPERATIVE STAGED MANAGEMENT

Natural history / staging (consensus, weak evidence -- descriptive, no RCT)

Frozen shoulder is self-limiting in most but typically lasts 12-18 months across 3 clinical stages (Reeves' classic model; staging boundaries overlap and are not sharply separable in practice -- flagged as weak/consensus evidence; the original Reeves model was a single prospective cohort of 49 patients, not an RCT) [Brigham SOC; Chan 2017; Reeves 1975 via Willmore 2020]:

(Stage durations from Brigham Standard of Care 2010 and Chan 2017: freezing 2-9 mo, frozen 4-12 mo, thawing 6-9 mo.)

Stepped non-operative interventions

1. Education / "supervised neglect" + analgesia -- many resolve with reassurance, activity modification and analgesia alone (Codman; Hsu 2011 review). Weak (cohort/expert).
2. Physiotherapy -- pendulum, PROM/AAROM/AROM, capsular stretching, joint mobilisation (grades I-II early for pain, III-IV later for tissue extensibility), scapular/posture work. Brigham: PT 1-2x/week in early stages (mainly HEP instruction), 2-3x/week in thawing. PT is best supported as an adjunct to mobilisation/injection/distension, not as a stand-alone cure (Itoi 2016 Current Concepts; Kelley/McClure/Leggin JOSPT 2009 guidance). Moderate; intensity/timing debated. Intensity caveat: end-range/high-intensity stretching is appropriate in the frozen/thawing phase but can be counter-productive in the acutely inflamed freezing phase -- match intensity to irritability (Kelley 2009).
3. Intra-articular corticosteroid (glenohumeral) -- superior to placebo and to physiotherapy for short-term (up to 4-12 weeks) pain and function; benefit wanes after ~3 months. Strong for short term (multiple RCTs; Koh 2016 systematic review of 10 RCTs; Cochrane Buchbinder shoulder injection review). BESS pathway: GH steroid recommended for short-term symptom control; long-term (>3 mo) benefit not demonstrated (Rupani/Gwilym BESS 2025). Earlier injection (freezing phase) is the rationale -- steroid targets the inflammatory component.
4. Hydrodilatation (distension arthrography) -- distends/ruptures the contracted capsule with saline +/- steroid +/- LA. A controlled, image-guided alternative to surgery. RCT/meta-analytic evidence is mixed: generally produces a transient functional/ROM gain, with no clear superiority over IA steroid alone in several network meta-analyses (Wu 2017 SR/MA of RCTs; Lin 2018 network MA). Some evidence hydrodilatation + steroid > steroid alone in refractory cases (Lee 2017 RCT). Low rate of needing later surgery after distension arthrogram (Nicholson 2020). Moderate; conflicting.

B. POST-OPERATIVE REHABILITATION (the "immediate aggressive ROM" protocols)

Surgery is reserved for cases recalcitrant to >=3-6 months of adequate non-operative care (Struyf 2024; Mullen 2025).

Arthroscopic capsular release (ACR)

• Controlled, direct-vision release of the contracted capsule (rotator interval, CHL, anterior +/- inferior +/- 360 degree capsulotomy; care re axillary nerve inferiorly). Allows graded release with a low risk of iatrogenic fracture or cuff tear (Kanbe 2018, n=255; Jerosch 2001 360 degree release). Achieves reliable gains in final forward elevation and may shorten recovery (most improved by ~4 months -- McAllister/CORR Insights 2025; Saade 2023 MA favoured ACR for AFE). A gentle, controlled manipulation is often performed as part of the arthroscopic release to confirm the gained range.

Consensus POST-OP phased timeline (applies after arthroscopic capsular release)

The hallmark is immediate motion, no protective sling, same-day/day-1 ROM to hold the range just won in theatre.

Representative published protocol (Kanbe 2018, J Orthop Surg Res, n=255, ACR): "passive, assisted-active and stooping (pendulum) exercises for forward flexion and external rotation commenced 1 day after surgery... after 2 weeks of passive exercise, patients began active exercise to strengthen the rotator cuff and scapular stabilisers... after 4-6 weeks patients returned to normal work without limitation." Many ACR series add an intra-articular steroid + controlled manipulation at the index procedure (Filip Struyf 2024; PMC5137660).

Post-surgical physiotherapy is universally agreed to be essential but is under-standardised -- there is no high-level RCT defining the optimal post-release regimen; protocols are consensus/expert and vary widely (Willmore 2020 Shoulder & Elbow, "Post-surgical physiotherapy in frozen shoulder: a review"). Weak/consensus.

KEY CONTROVERSIES

1. Evidence base for arthroscopic release. ACR gives a controlled, direct-vision release with a low iatrogenic fracture/cuff-tear risk and reliable gains in final elevation. Systematic reviews show consistently acceptable results, though there is no definitive RCT defining the optimal technique (Saade 2023 MA; McAllister 2025). Weak/moderate evidence (large cohorts).
2. Steroid timing. Strong short-term benefit (<12 wk) but no durable >3-month benefit; debate over injecting early (freezing/inflammatory phase) vs reserving for refractory cases (Koh 2016; Rupani/Gwilym BESS 2025; Lin 2018).
3. Aggressive vs gentle physiotherapy. High-intensity end-range stretching helps in the frozen/thawing phases but may worsen pain and prolong the condition if applied to the acutely inflamed freezing phase -- "intensity should match irritability" (Kelley/McClure 2009; Itoi 2016). Post-operatively, by contrast, aggressive immediate ROM is mandatory to prevent re-stiffening.
4. Hydrodilatation worth it? Transient benefit only and not clearly better than IA steroid alone in pooled RCT data (Wu 2017; Lin 2018), though some refractory-case RCT support (Lee 2017) and a low rate of needing later surgery (Nicholson 2020).
5. Does anything change the natural history? No intervention is proven to shorten the overall 12-18 month course in the highest-quality reviews; most accelerate symptom relief rather than alter end-point (Rookmoneea 2010 JBJS Br; Hsu 2011). Strong (negative).

EVIDENCE STRENGTH FLAGS (summary)

• STRONG (RCT / SR-MA): IA corticosteroid short-term benefit (Koh 2016 SR of 10 RCTs; Cochrane); hydrodilatation = transient, not superior to steroid (Wu 2017 SR-MA of RCTs; Lin 2018 network MA).
• MODERATE: end-range/scapular mobilisation (Yang 2012 RCT); ACR clinical outcomes (large cohorts -- Kanbe 2018 n=255; Jerosch 2001).
• WEAK / CONSENSUS ONLY: 3-stage natural-history model & stage durations (Reeves cohort, descriptive); the post-operative rehab protocol itself (no defining RCT; expert/consensus -- Willmore 2020); optimal ACR technique (published series are heterogeneous).

CITATIONS

RAG corpus (180,000+ Orthopaedic articles)

• Guyver P, Bruce D, Rees J. Frozen shoulder -- a stiff problem that requires a flexible approach. Maturitas. 2014.
• Kim J, Gahlot N, Park HB. Frozen shoulder: a narrative review of current treatment concepts and the underlying scientific evidence. Clinics in Shoulder and Elbow. 2025;28(4).
• Hsu JE, Anakwenze OA, Warrender WJ, et al. Current review of adhesive capsulitis. J Shoulder Elbow Surg. 2011;20(3):502-514.
• Koh KH. Corticosteroid injection for adhesive capsulitis in primary care: a systematic review of randomised clinical trials. Singapore Med J. 2016.
• Rupani N, Gwilym SE. British Elbow and Shoulder Society patient care pathway: Frozen shoulder. Shoulder & Elbow. 2025;17(4).
• Sheridan MA, Hannafin JA. Upper Extremity: Emphasis on Frozen Shoulder. Orthop Clin North Am. 2006.
• Chan H, Pua P, How C. Physical therapy in the management of frozen shoulder. Singapore Med J. 2017.
• Willmore EG, Millar NL, van der Windt D. Post-surgical physiotherapy in frozen shoulder: a review. Shoulder & Elbow. 2020;14(4).
• Lamplot JD, Lillegraven O, Brophy RH. Outcomes from conservative treatment of shoulder idiopathic adhesive capsulitis... Orthop J Sports Med. 2018.
• Itoi E, Arce G, Bain GI, et al. Shoulder Stiffness: Current Concepts and Concerns. Arthroscopy. 2016;32(7).
• Kanbe K. Clinical outcome of arthroscopic capsular release for frozen shoulder: essential technical points in 255 patients. J Orthop Surg Res. 2018;13(1). (post-op protocol: day-1 ROM, 4-6 wk RTW)
• Jerosch J. 360 degree arthroscopic capsular release in patients with adhesive capsulitis... Knee Surg Sports Traumatol Arthrosc. 2001;9(3).
• McAllister NB. CORR Insights: Releasing forces in adhesive capsulitis... Clin Orthop Relat Res. 2025.
• Saade F, van Rooij F, Saffarini M, et al. Management of shoulder stiffness following rotator cuff repair: a systematic review and meta-analysis. JSES Rev Rep Tech. 2023.
• Wu W, Chang K, Han D, et al. Effectiveness of glenohumeral joint dilatation for treatment of frozen shoulder: a systematic review and meta-analysis of RCTs. Sci Rep. 2017. (SR-MA of RCTs)
• Lin M, Hsiao M, Tu Y, et al. Comparative efficacy of intra-articular steroid injection and distension... a systematic review and network meta-analysis. Arch Phys Med Rehabil. 2018. (network MA)
• Lee D, Yoon S, Lee MY, et al. Capsule-preserving hydrodilatation with corticosteroid vs corticosteroid alone in refractory adhesive capsulitis: a randomized controlled trial. Arch Phys Med Rehabil. 2017. (RCT)
• Nicholson JA, Slader B, Martindale A, et al. Distension arthrogram in the treatment of adhesive capsulitis has a low rate of repeat intervention. Bone Joint J. 2020;102-B(5).
• Uppal HS. Frozen shoulder: a systematic review of therapeutic options. World J Orthop. 2015.
• Mullen JP, Hauer TM, Lau EN, et al. Adhesive capsulitis of the shoulder. Arthroscopy. 2025;41(7).
• Yang J, Jan M, Chang C, et al. Effectiveness of the end-range mobilization and scapular mobilization approach... a randomized control trial. Manual Therapy. 2012. (RCT)
• Rookmoneea M, et al. The effectiveness of interventions in the management of patients with primary frozen shoulder. J Bone Joint Surg Br. 2010;92-B(9).
• Struyf F. Frozen Shoulder. 2024 (surgical indication & post-op steroid + controlled manipulation).

Published rehab protocols (URLs)

• Brigham & Women's Hospital -- Standard of Care: Shoulder Adhesive Capsulitis (Dept of Rehabilitation Services, 2010): https://www.brighamandwomens.org/assets/BWH/patients-and-families/rehabilitation-services/pdfs/shoulder-adhesive-capsulitis.pdf (source for the 12-18 mo / 3-stage durations, capsular pattern, PT frequency 1-2x/wk early & 2-3x/wk thawing, mobilisation grades, steroid 4-6 wk short-term benefit).
• BESS (British Elbow & Shoulder Society) Frozen Shoulder patient care pathway -- Rupani & Gwilym, Shoulder & Elbow 2025 (GH steroid short-term only, no >3 mo benefit).
• Kanbe 2018 ACR open-access (post-op day-1 ROM protocol): https://pmc.ncbi.nlm.nih.gov/articles/PMC5857121/
• ChoosePT / APTA patient guide to frozen shoulder (lay phased overview): https://www.choosept.com/guide/physical-therapy-guide-frozen-shoulder-adhesive-capsulitis